Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meghna S Trivedi

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
JAMA Oncology|February 29, 2024
Increasing the Uptake of Cancer Risk Management Strategies for Women With BRCA1/2 Sequence VariationsMeghna S Trivedi, Katrina A Armstrong
Cancer Prevention Research (Philadelphia, Pa.)|June 15, 2017
Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma <i>In Situ</i>Meghna S Trivedi, Austin M Coe, Alejandro Vanegas, et al.
Critical Reviews in Oncology/Hematology|April 24, 2025
Review of the contribution of clinical and genetic factors to the racial disparity in taxane-induced peripheral neuropathyNam Nguyen-Hoang, Maisa Nazzal, Bryan P Schneider, et al.
The Breast Journal|March 22, 2017
The Impact of Mental Illness on Uptake of Genetic Counseling for Hereditary Breast Cancer and Ovarian Cancer in a Multiethnic Cohort of Breast Cancer PatientsMarra G Ackerman, Peter A Shapiro, Austin Coe, et al.
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Programmed death 1 immune checkpoint inhibitorsMeghna S Trivedi, Brianna Hoffner, Jennifer L Winkelmann, et al.
BMC Medical Informatics and Decision Making|August 4, 2022
Qualitative analysis of shared decision-making for chemoprevention in the primary care setting: provider-related barriersTarsha Jones, Thomas Silverman, Ashlee Guzman, et al.
JAMA Network Open|July 23, 2025
Germline Genetic Testing in Patients With Solid Malignant TumorsMatthew E Fine, Adina Estrin, Alissa Michel, et al.
Cancer Genetics|May 13, 2019
Uptake of genetic testing for germline BRCA1/2 pathogenic variants in a predominantly Hispanic populationJulia E McGuinness, Meghna S Trivedi, Thomas Silverman, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
Automatic Genetic Risk Assessment Calculation Using Breast Cancer Family History Data from the EHR compared to Self-ReportMargaret Sin, Julia E McGuinness, Meghna S Trivedi, et al.
Oncology Nursing Forum|December 18, 2019
Mental Illness and BRCA1/2 Genetic Testing Intention Among Multiethnic Women Undergoing Screening MammographyTarsha Jones, Katherine Freeman, Marra Ackerman, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
JAMA Oncology|February 29, 2024
Increasing the Uptake of Cancer Risk Management Strategies for Women With BRCA1/2 Sequence VariationsMeghna S Trivedi, Katrina A Armstrong
Cancer Prevention Research (Philadelphia, Pa.)|June 15, 2017
Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma <i>In Situ</i>Meghna S Trivedi, Austin M Coe, Alejandro Vanegas, et al.
Critical Reviews in Oncology/Hematology|April 24, 2025
Review of the contribution of clinical and genetic factors to the racial disparity in taxane-induced peripheral neuropathyNam Nguyen-Hoang, Maisa Nazzal, Bryan P Schneider, et al.
The Breast Journal|March 22, 2017
The Impact of Mental Illness on Uptake of Genetic Counseling for Hereditary Breast Cancer and Ovarian Cancer in a Multiethnic Cohort of Breast Cancer PatientsMarra G Ackerman, Peter A Shapiro, Austin Coe, et al.
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Programmed death 1 immune checkpoint inhibitorsMeghna S Trivedi, Brianna Hoffner, Jennifer L Winkelmann, et al.
BMC Medical Informatics and Decision Making|August 4, 2022
Qualitative analysis of shared decision-making for chemoprevention in the primary care setting: provider-related barriersTarsha Jones, Thomas Silverman, Ashlee Guzman, et al.
JAMA Network Open|July 23, 2025
Germline Genetic Testing in Patients With Solid Malignant TumorsMatthew E Fine, Adina Estrin, Alissa Michel, et al.
Cancer Genetics|May 13, 2019
Uptake of genetic testing for germline BRCA1/2 pathogenic variants in a predominantly Hispanic populationJulia E McGuinness, Meghna S Trivedi, Thomas Silverman, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
Automatic Genetic Risk Assessment Calculation Using Breast Cancer Family History Data from the EHR compared to Self-ReportMargaret Sin, Julia E McGuinness, Meghna S Trivedi, et al.
Oncology Nursing Forum|December 18, 2019
Mental Illness and BRCA1/2 Genetic Testing Intention Among Multiethnic Women Undergoing Screening MammographyTarsha Jones, Katherine Freeman, Marra Ackerman, et al.
Pageof 4